Tranxenogen Inc, based in Shrewsbury, MA, is a leading provider of high-volume recombinant therapeutic proteins produced in transgenic chicken eggs. Their cost-effective alternative offers increased flexibility, scalability, improved time to market, lower capital requirements, and enhanced bottom line for their clients.
With a focus on avian transgenics, Tranxenogen Inc utilizes cutting-edge technology to deliver innovative solutions in the production of therapeutic proteins. Their forward-looking approach, backed by rigorous research and development, positions them as a trusted partner in the biotechnology industry.
Generated from the website